Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS2411 in Functional Dyspepsia
NCT05248802Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Dec 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS2411 in functional dyspepsia (FD), sponsored by Dexa Medica. Started Dec 2022; status: completed.
02
Drugs
DLBS2411
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05248802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248802.